How does BMLK.F's PE Ratio compare to its peers?

BMLK.F is good value based on its Price-To-Earnings Ratio (18.5x) compared to the peer average (22.1x).

How does BMLK.F's PE Ratio compare vs other companies in the US Healthcare Industry?

BMLK.F is good value based on its Price-To-Earnings Ratio (18.5x) compared to the US Healthcare industry average (23.6x).

What is BMLK.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate BMLK.F's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of BMLK.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

BMLK.F ($18.2) is trading below our estimate of [[fair value]] ($28.28)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

BML (OTCPK:BMLK.F) - Stock Price, News & Analysis

BMLK.F Stock Overview

Provides laboratory testing and related services in Japan. More details

BMLK.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	1/6
Financial Health	6/6
Dividends	4/6

Rewards

Trading at 35.6% below our estimate of its fair value

Risk Analysis

Shares are highly illiquid

High level of non-cash earnings

Dividend of 4.84% is not well covered by free cash flows

My Notes

Capture your thoughts, links and company narrative

BML, Inc. Competitors

AMN Healthcare Services

NYSE:AMN

US$993.0m

SBC Medical Group Holdings

NasdaqGM:SBC

US$526.1m

National Research

NasdaqGS:NRC

US$388.3m

Pennant Group

NasdaqGS:PNTG

US$935.0m

Price History & Performance

Summary of share price highs, lows and changes for BML
Historical stock prices
Current Share Price	JP¥18.20
52 Week High	JP¥18.20
52 Week Low	JP¥18.20
Beta	0.25
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	11.66%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BMLK.F	US Healthcare	US Market
7D	0%	-2.7%	0.2%
1Y	n/a	-4.7%	22.0%

Return vs Industry: Insufficient data to determine how BMLK.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how BMLK.F performed against the US Market.

Price Volatility

Is BMLK.F's price volatile compared to industry and market?
BMLK.F volatility
BMLK.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.1%
Market Average Movement	6.1%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: BMLK.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BMLK.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1955	4,513	Kensuke Kondo	www.bml.co.jp

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services.

BML, Inc. Fundamentals Summary

How do BML's earnings and revenue compare to its market cap?
BMLK.F fundamental statistics
Market cap	US$746.33m
Earnings (TTM)	US$40.35m
Revenue (TTM)	US$920.18m

18.5x

P/E Ratio

0.8x

P/S Ratio

Is BMLK.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BMLK.F income statement (TTM)
Revenue	JP¥139.23b
Cost of Revenue	JP¥93.50b
Gross Profit	JP¥45.73b
Other Expenses	JP¥39.62b
Earnings	JP¥6.11b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	156.51
Gross Margin	32.84%
Net Profit Margin	4.38%
Debt/Equity Ratio	0%

How did BMLK.F perform over the long term?

See historical performance and comparison

Dividends

4.8%

Current Dividend Yield

57%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 00:40
End of Day Share Price	2025/01/24 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BML, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Mitsuko Miyasako	Barclays
Hidemaru Yamaguchi	Citigroup Global Markets Japan Inc.
Yuki Yamazaki	Daiwa Securities Co. Ltd.